DEN220058 is the FDA 510(k) clearance record for BT-001, a class II device, cleared for Better Therapeutics on under FDA product code QXC (Diabetes Digital Therapeutic Device). FDA's definition for product code QXC reads: "A diabetes digital behavioral therapeutic device is a prescription use software device that provides digital behavioral therapy to aid in the management of diabetes. This device is intended to provide limited secondary benefit to patients...". FDA records list one 510(k) clearance for Better Therapeutics. As of , FDA records show no recalls naming DEN220058.
Clearance record
- Decision date
- Received
- (289 days to decision)
- Product code
- QXC Diabetes Digital Therapeutic Device
- Regulation
- 21 CFR 880.5735
- Device class
- Class II
- Review panel
- General Hospital
- Applicant
- Better Therapeutics 548 Market St. #49404, San Francisco CA
- Third party review
- No
Clearances, product code QXC
Trailing 12 monthsFDA records hold no clearances under product code QXC in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
